Search results
Results from the WOW.Com Content Network
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
A review in the Journal of the American Medical Association stated "Zimmer and Morgan provide an extraordinarily well-researched and passionately argued book on the biomedical and sociological issues raised in today's debate about marijuana. In their desire to 'set the record straight', however, they sometimes sacrifice even-handedness for impact."
A 2004 literature review on the subject concluded that cannabis use is associated with a two-fold increase in the risk of psychosis, but that cannabis use is "neither necessary nor sufficient" to cause psychosis. [49] A French review from 2009 came to a conclusion that cannabis use, particularly that before age 15, was a factor in the ...
Age. The risk of most causes of joint pain increases with age. This may be due to increased wear and stress on joints over time and a higher likelihood of other underlying medical conditions ...
"Repetitive impact to an injured joint can lead to long-term consequences including permanent damage to the cartilage—arthritis—or intractable pain and inflammation," Dr. Zarin explains. It's ...
Cannabis is the most widely used illicit drug in the Western world. [3] In the United States, 10-20% of those who begin the use of cannabis daily will later become dependent. [4] [5] Cannabis use can lead to addiction, which is defined as "when the person cannot stop using the drug even though it interferes with many aspects of his or her life."
In January 2008, the American College of Physicians called for a review of cannabis's Schedule I classification in its position paper titled "Supporting Research into the Therapeutic Role of Marijuana" It stated therein: "Position 4: ACP urges an evidence-based review of marijuana's status as a Schedule I controlled substance to determine ...
The stated mission of NIDA is to support research on the causes, consequences, prevention, and treatment of drug abuse and drug addiction, and not the medicinal uses of drugs. [93] Consequently, many studies on the therapeutic benefits of cannabis were either denied or altered to comply with the limited scope and mission of NIDA. [86]